Symbols / RDGT Stock $1.76 -4.35% Ridgetech, Inc.

Healthcare • Pharmaceutical Retailers • China • NCM
RDGT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Pharmaceutical Retailers
CEO Mr. Ming Zhao
Exch · Country NCM · China
Market Cap 1.58M
Enterprise Value -9.20M
Income -2.01M
Sales 119.94M
FCF (ttm) 6.04M
Book/sh 762.91
Cash/sh 357.01
Employees 61
Insider 10d —
IPO Oct 01, 2009
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 0.01
P/B 0.00
P/C —
EV/EBITDA 10.62
EV/Sales -0.08
Quick Ratio 1.35
Current Ratio 1.82
Debt/Eq 15.65
LT Debt/Eq —
EPS (ttm) -54.61
EPS next Y —
EPS Growth —
Revenue Growth -11.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2011-02-15
Earnings (prior) 2011-02-15
ROA -1.23%
ROE -8.02%
ROIC —
Gross Margin 3.24%
Oper. Margin -0.12%
Profit Margin 10.35%
Shs Outstand 898.91K
Shs Float 34.28K
Insider Own 1.67%
Instit Own 0.01%
Short Float 13.92%
Short Ratio 0.11
Short Interest 123.02K
52W High 760.50
vs 52W High -99.77%
52W Low 1.62
vs 52W Low 8.64%
Beta 0.18
Impl. Vol. —
Rel Volume 0.23
Avg Volume 437.14K
Volume 101.76K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.84
Price $1.76
Change -4.35%
About

Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.76
Latest analyst target
3. DCF / Fair value
$120.96
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.76
Low
—
High
—
Mean
—
News
RSS: Latest RDGT news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
119.97
-3.24%
123.99
+3.16%
120.20
-26.88%
164.39
Operating Revenue
119.97
-3.24%
123.99
+3.16%
120.20
-26.88%
164.39
Cost Of Revenue
116.13
-2.50%
119.12
+2.16%
116.60
-8.82%
127.87
Reconciled Cost Of Revenue
116.13
-2.50%
119.12
+2.16%
116.60
-8.82%
127.87
Gross Profit
3.84
-21.31%
4.88
+35.46%
3.60
-90.14%
36.52
Operating Expense
4.87
+13.82%
4.28
-74.45%
16.76
-57.09%
39.06
Selling General And Administration
4.87
+13.82%
4.28
-74.45%
16.76
-57.09%
39.06
Selling And Marketing Expense
1.53
+64.22%
0.93
-26.21%
1.27
-95.90%
30.88
General And Administrative Expense
3.34
-0.24%
3.35
-78.40%
15.50
+89.29%
8.19
Salaries And Wages
0.00
0.00
-100.00%
10.36
0.00
Other Gand A
3.34
-0.24%
3.35
-34.83%
5.14
-37.25%
8.19
Total Expenses
121.01
-1.94%
123.40
-7.47%
133.36
-20.11%
166.94
Operating Income
-1.04
-273.69%
0.60
+104.53%
-13.16
-417.16%
-2.55
Total Operating Income As Reported
-1.04
-273.69%
0.60
+104.53%
-13.16
-388.60%
-2.69
EBITDA
4.98
-16.72%
5.98
+148.06%
-12.44
-2045.83%
-0.58
Normalized EBITDA
4.98
-34.36%
7.59
+175.57%
-10.04
-2229.18%
-0.43
Reconciled Depreciation
6.02
+11.73%
5.38
+649.95%
0.72
-42.86%
1.26
EBIT
-1.04
-273.69%
0.60
+104.53%
-13.16
-616.74%
-1.84
Total Unusual Items
—
-1.61
+33.09%
-2.40
-1514.55%
-0.15
Total Unusual Items Excluding Goodwill
—
-1.61
+33.09%
-2.40
-1514.55%
-0.15
Special Income Charges
—
0.00
0.00
+100.00%
-0.15
Impairment Of Capital Assets
—
0.00
0.00
-100.00%
0.15
Write Off
—
—
0.00
-100.00%
0.15
Net Income
10.19
+340.76%
-4.23
+79.97%
-21.14
-562.21%
-3.19
Pretax Income
-0.95
-14.94%
-0.83
+94.64%
-15.44
-635.75%
-2.10
Net Non Operating Interest Income Expense
0.09
-53.06%
0.20
+526.19%
0.03
-77.39%
0.14
Interest Expense Non Operating
—
0.01
-79.34%
0.07
-74.89%
0.26
Net Interest Income
0.09
-53.06%
0.20
+526.19%
0.03
-77.39%
0.14
Interest Expense
—
0.01
-79.34%
0.07
-74.89%
0.26
Interest Income Non Operating
0.09
-53.06%
0.20
+526.19%
0.03
-92.14%
0.40
Interest Income
0.09
-53.06%
0.20
+526.19%
0.03
-92.14%
0.40
Other Income Expense
-0.01
+99.50%
-1.62
+29.83%
-2.31
-853.06%
0.31
Other Non Operating Income Expenses
-0.01
+39.04%
-0.01
-114.48%
0.09
-79.73%
0.46
Gain On Sale Of Security
—
-1.61
+33.09%
-2.40
—
Tax Provision
0.50
+1317.33%
-0.04
-110.48%
0.39
-64.12%
1.10
Tax Rate For Calcs
0.00
+400.00%
0.00
-80.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
+100.00%
-0.08
+86.62%
-0.60
-1514.55%
-0.04
Net Income Including Noncontrolling Interests
10.20
+340.89%
-4.23
+79.97%
-21.14
-560.92%
-3.20
Net Income From Continuing Operation Net Minority Interest
-1.46
-85.77%
-0.79
+95.04%
-15.84
-396.07%
-3.19
Net Income From Continuing And Discontinued Operation
10.19
+340.76%
-4.23
+79.97%
-21.14
-562.21%
-3.19
Net Income Continuous Operations
-1.45
-85.08%
-0.79
+95.04%
-15.84
-395.11%
-3.20
Net Income Discontinuous Operations
11.65
+437.94%
-3.45
+34.98%
-5.30
—
Minority Interests
-0.01
-38557.14%
0.00
-94.44%
0.00
-95.97%
0.01
Normalized Income
-1.46
-296.85%
0.74
+105.28%
-14.03
-355.55%
-3.08
Net Income Common Stockholders
10.19
+340.76%
-4.23
+79.97%
-21.14
-562.21%
-3.19
Diluted EPS
1.84
+162.80%
-2.93
+92.92%
-41.40
-125.09%
-18.39
Basic EPS
1.84
+162.80%
-2.93
+92.92%
-41.40
-125.09%
-18.39
Basic Average Shares
5.54
+283.80%
1.44
+183.28%
0.51
+192.95%
0.17
Diluted Average Shares
5.54
+283.80%
1.44
+183.28%
0.51
+192.95%
0.17
Diluted NI Availto Com Stockholders
10.19
+340.76%
-4.23
+79.97%
-21.14
-562.21%
-3.19
Line Item Trend 2023-03-31
Total Assets
90.97
Current Assets
64.48
Cash Cash Equivalents And Short Term Investments
18.81
Cash And Cash Equivalents
18.81
Other Short Term Investments
—
Receivables
16.84
Accounts Receivable
14.10
Gross Accounts Receivable
16.41
Allowance For Doubtful Accounts Receivable
-2.31
Other Receivables
2.73
Inventory
15.31
Finished Goods
15.31
Prepaid Assets
0.67
Restricted Cash
12.76
Assets Held For Sale Current
—
Other Current Assets
0.09
Total Non Current Assets
26.49
Net PPE
19.03
Gross PPE
31.04
Accumulated Depreciation
-12.02
Properties
0.00
Land And Improvements
1.74
Buildings And Improvements
20.00
Machinery Furniture Equipment
6.17
Other Properties
—
Leases
3.13
Goodwill And Other Intangible Assets
3.89
Goodwill
—
Other Intangible Assets
3.89
Investments And Advances
1.77
Non Current Prepaid Assets
1.04
Other Non Current Assets
0.77
Total Liabilities Net Minority Interest
74.30
Current Liabilities
66.54
Payables And Accrued Expenses
31.45
Payables
30.70
Accounts Payable
26.99
Other Payable
1.31
Current Accrued Expenses
0.76
Total Tax Payable
1.71
Current Debt And Capital Lease Obligation
34.39
Current Debt
29.26
Other Current Borrowings
—
Current Capital Lease Obligation
5.13
Current Deferred Liabilities
0.70
Current Deferred Revenue
0.70
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
7.77
Liabilities Heldfor Sale Non Current
—
Long Term Debt And Capital Lease Obligation
7.77
Long Term Capital Lease Obligation
7.77
Non Current Deferred Liabilities
—
Non Current Deferred Taxes Liabilities
—
Stockholders Equity
18.01
Common Stock Equity
18.01
Capital Stock
0.28
Common Stock
0.28
Preferred Stock
0.00
Share Issued
1.18
Ordinary Shares Number
1.18
Treasury Shares Number
0.00
Additional Paid In Capital
83.96
Retained Earnings
-69.27
Gains Losses Not Affecting Retained Earnings
3.04
Minority Interest
-1.35
Other Equity Adjustments
3.04
Total Equity Gross Minority Interest
16.67
Total Capitalization
18.01
Working Capital
-2.05
Invested Capital
47.27
Total Debt
42.16
Net Debt
10.45
Capital Lease Obligations
12.90
Net Tangible Assets
14.13
Tangible Book Value
14.13
Current Notes Payable
29.26
Derivative Product Liabilities
—
Duefrom Related Parties Current
0.00
Dueto Related Parties Current
0.68
Line Of Credit
—
Notes Receivable
0.02
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
1.25
+139.54%
-3.16
+3.90%
-3.28
+39.04%
-5.39
Cash Flow From Continuing Operating Activities
1.25
+139.54%
-3.16
+3.90%
-3.28
+39.04%
-5.39
Net Income From Continuing Operations
10.20
+340.89%
-4.23
+79.97%
-21.14
-560.92%
-3.20
Depreciation Amortization Depletion
6.02
+11.73%
5.38
+649.95%
0.72
-42.86%
1.26
Depreciation
6.02
+11.73%
5.38
+649.95%
0.72
-42.86%
1.26
Depreciation And Amortization
6.02
+11.73%
5.38
+649.95%
0.72
-42.86%
1.26
Other Non Cash Items
—
—
—
0.00
Stock Based Compensation
0.00
0.00
-100.00%
10.36
0.00
Asset Impairment Charge
0.09
+134.36%
-0.25
-103.29%
7.58
+596.35%
1.09
Deferred Tax
-0.03
—
—
—
Deferred Income Tax
-0.03
—
—
—
Operating Gains Losses
-15.76
-1018.93%
1.71
-28.62%
2.40
—
Gain Loss On Investment Securities
—
1.61
-33.09%
2.40
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.11
0.00
0.00
Change In Working Capital
0.73
+112.71%
-5.77
-80.07%
-3.21
+29.29%
-4.53
Change In Receivables
-1.75
+37.03%
-2.78
+20.96%
-3.51
+22.74%
-4.54
Changes In Account Receivables
10.04
+656.43%
-1.80
+28.73%
-2.53
+4.72%
-2.66
Change In Inventory
0.41
+123.88%
-1.70
-225.26%
-0.52
-134.31%
1.52
Change In Prepaid Assets
-0.34
+59.28%
-0.84
-515.49%
0.20
+217.58%
-0.17
Change In Payables And Accrued Expense
8.94
+50.91%
5.92
+667.50%
0.77
+133.60%
-2.30
Change In Payable
8.94
+50.91%
5.92
+667.50%
0.77
+133.60%
-2.30
Change In Account Payable
-21.13
-452.02%
6.00
+239.97%
1.77
+149.62%
-3.56
Change In Other Working Capital
-0.16
-12.56%
-0.14
+86.02%
-1.04
-252.59%
0.68
Change In Other Current Assets
-1.72
-3814.93%
-0.04
-104.94%
0.89
+219.19%
0.28
Change In Other Current Liabilities
-4.64
+25.09%
-6.19
0.00
0.00
Investing Cash Flow
-18.14
-789.04%
-2.04
-545.32%
-0.32
-3.25%
-0.31
Cash Flow From Continuing Investing Activities
-18.14
-789.04%
-2.04
-545.32%
-0.32
-3.25%
-0.31
Net PPE Purchase And Sale
-0.62
+28.18%
-0.86
-186.56%
-0.30
+0.06%
-0.30
Purchase Of PPE
-0.62
+28.18%
-0.86
-186.56%
-0.30
+0.06%
-0.30
Capital Expenditure
-0.62
+33.39%
-0.92
-196.31%
-0.31
-1.82%
-0.31
Net Investment Purchase And Sale
—
—
0.00
0.00
Purchase Of Investment
—
—
—
0.00
Sale Of Investment
—
—
0.00
0.00
Net Business Purchase And Sale
-17.52
-1469.58%
-1.12
-25390.11%
-0.00
0.00
Purchase Of Business
-22.35
-1902.60%
-1.12
-25390.11%
-0.00
0.00
Gain Loss On Sale Of Business
-15.76
0.00
0.00
—
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.07
-424.29%
-0.01
-82.17%
-0.01
Purchase Of Intangibles
0.00
+100.00%
-0.07
-424.29%
-0.01
-82.17%
-0.01
Financing Cash Flow
1.51
-81.19%
8.00
+238.28%
2.37
-51.08%
4.84
Cash Flow From Continuing Financing Activities
1.51
-81.19%
8.00
+238.28%
2.37
-51.08%
4.84
Net Issuance Payments Of Debt
-4.95
-219.15%
4.16
+200.90%
-4.12
-199.33%
4.15
Issuance Of Debt
51.69
-10.87%
57.99
+0.05%
57.97
-11.33%
65.37
Repayment Of Debt
-56.64
-5.22%
-53.83
+13.29%
-62.09
-1.41%
-61.22
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
0.00
0.00
+100.00%
-1.81
+30.70%
-2.61
Net Long Term Debt Issuance
0.00
0.00
+100.00%
-1.81
+30.70%
-2.61
Short Term Debt Issuance
51.69
-10.87%
57.99
+0.05%
57.97
-11.33%
65.37
Short Term Debt Payments
-56.64
-5.22%
-53.83
+10.68%
-60.27
-2.84%
-58.61
Net Short Term Debt Issuance
-4.95
-219.15%
4.16
+280.08%
-2.31
-134.14%
6.76
Net Common Stock Issuance
7.63
+194.76%
2.59
-64.65%
7.33
0.00
Proceeds From Stock Option Exercised
—
—
0.00
0.00
Net Other Financing Charges
-1.17
-193.37%
1.26
+249.92%
-0.84
-221.73%
0.69
Changes In Cash
-15.38
-647.59%
2.81
+327.73%
-1.23
-44.23%
-0.86
Effect Of Exchange Rate Changes
1.05
+169.65%
-1.51
+40.62%
-2.54
-266.57%
1.52
Beginning Cash Position
32.87
+4.13%
31.57
-10.66%
35.34
+1.92%
34.67
End Cash Position
18.54
-43.60%
32.87
+4.13%
31.57
-10.66%
35.34
Free Cash Flow
0.63
+115.51%
-4.08
-13.46%
-3.60
+36.84%
-5.69
Interest Paid Supplemental Data
0.01
-53.77%
0.01
-79.05%
0.06
-75.23%
0.26
Income Tax Paid Supplemental Data
0.14
-7.76%
0.15
+134.06%
0.06
+1509.81%
0.00
Change In Income Tax Payable
1.31
+238.64%
-0.95
-318.97%
0.43
-62.73%
1.16
Change In Tax Payable
1.31
+238.64%
-0.95
-318.97%
0.43
-62.73%
1.16
Common Stock Issuance
7.63
+194.76%
2.59
-64.65%
7.33
0.00
Issuance Of Capital Stock
7.63
+194.76%
2.59
-64.65%
7.33
0.00
Sale Of Business
4.83
0.00
0.00
—
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category